Phase 2Heart FailureCompleted
JK07 (Salubris Biotherapeutics)
Phase 2 — Chronic Heart Failure
Indication: Heart Failure
Sponsor: Salubris Biotherapeutics (JK07 Bio) · JK07.2.01 · NCT06369298
About this study
Enrollment closed early in 2026 per sponsor decision.
Study details
- Sponsor
- Salubris Biotherapeutics (JK07 Bio)
- Protocol
- JK07.2.01
- Phase
- Phase 2
- Indication
- Phase 2 — Chronic Heart Failure
- Status
- Completed
I'm a sponsor / CRO →
Discuss enrollment, capacity, and operational fit.
I might be eligible — call (786) 703-5941 →
Free, no-obligation pre-screen in English / Spanish / Haitian Creole.
Participation in any clinical trial is voluntary and requires written informed consent reviewed by an Institutional Review Board (IRB) before any study procedure. You may withdraw at any time. Website content is informational and is not a substitute for medical advice from a licensed clinician.